MiNK Therapeutics, Inc. (NASDAQ:INKT) Q1 2026 Earnings Call Transcript
MiNK Therapeutics, Inc. (NASDAQ:INKT) Q1 2026 Earnings Call Transcript May 15, 2026MiNK Therapeutics, Inc. beats earnings expectations. Reported EPS is $-0.57, expectations were $-0.77.
